NEW >> Many autoimmune & inflammatory diseases disproportionately affect women. In this article, Jenna Riffell explores the unmet need & outlines some opportunities for #biopharma companies >> https://lnkd.in/eVKrDmjw #pharmaceuticals #biotech #autoimmune #inflammatorydiseases
Blue Matter
Unternehmensberatung
South San Francisco, California 38.111 Follower:innen
New Ideas. Better Results.
Info
Our Work Blue Matter is a specialized management consulting firm, founded in San Francisco with offices in the US and Europe. We work with life sciences clients to address business issues across the company and product value chain. Our collaborations with bio-pharmaceutical industry leaders focus on providing the strategic insights necessary to create and achieve their visions. Our Story Blue Matter was born out of a vision to bring together a group of people that are passionate about applying consulting skills to help shape great ideas, products, and companies. Blue Matter is founded on the principle of placing the client business issue at the center of every engagement, developing a customized approach, and staffing the engagement appropriately to ensure that we achieve the desired results. Our Team Our team includes experienced strategy consultants with significant professional and educational experience relevant to the life science industry. We work collaboratively to solve the problems of senior leaders of life science companies, and deliver value through providing innovative and actionable solutions. We value personal and professional growth, and emphasize our employees’ development as a key success metric for the company. We are actively looking for qualified new team members. For more information, contact [email protected] for US-based opportunities and [email protected] for Europe-based opportunities.
- Website
-
http://www.bluematterconsulting.com
Externer Link zu Blue Matter
- Branche
- Unternehmensberatung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- South San Francisco, California
- Art
- Privatunternehmen
- Gegründet
- 2012
Orte
Beschäftigte von Blue Matter
Updates
-
The annual meeting of American Society of Clinical Oncology (ASCO) is nearly here (May 30-June 3 in Chicago)! The Blue Matter team will be attending to see the latest in #CancerResearch & meet with clients & colleagues. Be sure to connect with our team there: Mary Lee, Pankaj Oza, Chirag Ghai, Naina Shehzeen A., Shankar Sundar, Lily Sung, & Priya Kumar https://lnkd.in/dkv9Kv8p #ASCO25 #cancer #oncology #biotech #pharmaceuticals
-
-
Blue Matter hat dies direkt geteilt
NEW >> Part 2 in our series on the potential impact of #MostFavoredNation pricing for #pharmaceuticals. In this article, we consider the potential impacts on #biopharma companies' customers & channel partners >> https://lnkd.in/e4zTivdn Authors: Kurt Hartman, Naina Shehzeen A., Kavisha Shah, & Steve Schollmeyer #biotech #marketaccess #MFNpricing #MFN
-
NEW >> Part 2 in our series on the potential impact of #MostFavoredNation pricing for #pharmaceuticals. In this article, we consider the potential impacts on #biopharma companies' customers & channel partners >> https://lnkd.in/e4zTivdn Authors: Kurt Hartman, Naina Shehzeen A., Kavisha Shah, & Steve Schollmeyer #biotech #marketaccess #MFNpricing #MFN
-
The annual Congress of EULAR - European Alliance of Associations for Rheumatology is coming up in Barcelona, 11-14 June. Jenna Riffell will be attending to see the latest in #rheumatology, as well as meet with clients & colleagues. Be sure to connect with her there! #EULAR2025 https://lnkd.in/d2sBzqN
-
-
Medical Affairs Success Factor 5 - Insights-Strategy-Action Loop Don't bury insights in slide decks... When properly harnessed, #MedicalAffairs insights refine strategy, direct resources, & drive enterprise value. But how can MA empower team members to generate actionable insights & make sure they get applied to the real world? Learn more in our latest report by Chirag Ghai & Thomas Quirk >> https://lnkd.in/e3JQ8f5E
-
Medical Affairs Success Factor 4 - Capabilities & Systems Increasingly, #MedicalAffairs needs a fit-for-purpose, scalable “system” in place to create insights, generate evidence, tell the scientific story, & more. But why? And what are the essential elements? Find out in our latest report by Chirag Ghai & Thomas Quirk >> https://lnkd.in/e3JQ8f5E
-
-
The annual meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research concluded in Montreal late last week. Here, Chirag Ghai, Tom Bernstein, & Cameron Wong provide a concise look at the key topics discussed at the conference >> https://lnkd.in/eyGgua-w
-
-
Confused about the possibility of #MostFavoredNation pricing for prescription pharmaceuticals? Here, we explore what's known & unknown, how President Trump's #ExecutiveOrder fits into the larger picture, & some strategic questions #biopharma leaders might need to ask themselves. (Part 1 in a series, by Kurt Hartman, Naina Shehzeen A., & Steve Schollmeyer) >> https://lnkd.in/eBgmQEy8 #biotech #pharmaceuticals #drugprices
-
-
Much has been written over the past few days about the Trump administration's executive order of May 12 regarding #MostFavoredNation pricing for prescription pharmaceuticals. In this article, we take a look at what's known, what's unknown, how this EO fits into the larger picture, & some strategic questions #biopharma leaders might need to ask themselves. This is part 1 in an upcoming series >> https://lnkd.in/eBgmQEy8 Authors: Kurt Hartman, Naina Shehzeen A., & Steve Schollmeyer #biotech #pharmaceuticals #executiveorder #MFN #drugpricing